Total Funding
37
64
Total FundingSeries A raised
Growth Score 37 in past quarter
-3 pts
Heat Score 64 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43412
X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.
Ulf Wiinberg: President & CEO- Robert Ruffolo: DirectorPast Role: Eli Lilly, Team Member
About the Company
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will
provoke an entirely new and effective immune response – so that they can finally beat these pathogens.
The company was founded in 2015 and based in Jupiter, Florida.